Elixxer Ltd

PINK:ELIXF USA Drug Manufacturers - Specialty & Generic
Market Cap
$69.17K
Market Cap Rank
#44848 Global
#14166 in USA
Share Price
$0.01
Change (1 day)
+0.00%
52-Week Range
$0.01 - $0.01
All Time High
$70.35
About

Elixxer Ltd. does not have significant operations. The company invests in the cultivation and production of cannabis products. Elixxer Ltd. is based in Montreal, Canada.

Elixxer Ltd (ELIXF) - Total Liabilities

Latest total liabilities as of September 2025: $17.22 Million USD

Based on the latest financial reports, Elixxer Ltd (ELIXF) has total liabilities worth $17.22 Million USD as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Elixxer Ltd - Total Liabilities Trend (2014–2024)

This chart illustrates how Elixxer Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Elixxer Ltd Competitors by Total Liabilities

The table below lists competitors of Elixxer Ltd ranked by their total liabilities.

Company Country Total Liabilities
CHINA AVIATION OIL
BE:VZ8
Germany €835.17 Million
MERAVEST CAP.
DU:AEE1
Germany €116.67K
Probility Media Corp
PINK:PBYA
USA $16.66 Million
Cake Box Holdings PLC
LSE:CBOX
UK GBX34.37 Million
Agri-Tech (India) Limited
NSE:AGRITECH
India ₹10.10 Million

Liability Composition Analysis (2014–2024)

This chart breaks down Elixxer Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.01 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -1.14 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 7.93 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Elixxer Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Elixxer Ltd (2014–2024)

The table below shows the annual total liabilities of Elixxer Ltd from 2014 to 2024.

Year Total Liabilities Change
2024-12-31 $15.23 Million +22.72%
2023-12-31 $12.41 Million +38.98%
2022-12-31 $8.93 Million +80.19%
2021-12-31 $4.95 Million -46.47%
2020-12-31 $9.26 Million +117.40%
2019-12-31 $4.26 Million -19.02%
2019-09-30 $5.26 Million +190.48%
2018-12-31 $1.81 Million +159.05%
2017-12-31 $698.73K +136.49%
2016-12-31 $295.46K +18.44%
2016-06-30 $249.46K +233.51%
2015-12-31 $74.80K +60.34%
2014-12-31 $46.65K --